| Issue |
Section |
Title |
File |
| Vol 10, No 10 (2010) |
Oncology |
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer |
(Eng)
|
| Vol 10, No 10 (2010) |
Oncology |
Focal Adhesion Kinase as a Cancer Therapy Target |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Editorial [Hot topic: Focal Adhesion Kinase Signaling in Cancer- Part II (Guest Editor: Vita M. Golubovskaya)] |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
FAK and p53 Protein Interactions |
(Eng)
|
| Vol 11, No 7 (2011) |
Oncology |
Inhibition of Hyaluronan Synthase-3 Decreases Subcutaneous Colon Cancer Growth by Increasing Apoptosis |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Editorial (Hot Topic: Survival Signaling Through Focal Adhesion Kinase in Tumors) |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
A Small-molecule Inhibitor, 5'-O-Tritylthymidine, Targets FAK and Mdm-2 Interaction, and Blocks Breast and Colon Tumorigenesis in vivo |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
Mitoxantrone Targets the ATP-binding Site of FAK, Binds the FAK Kinase Domain and Decreases FAK, Pyk-2, c-Src, and IGF-1R In Vitro Kinase Activities |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
FAK and Nanog Cross Talk with p53 in Cancer Stem Cells |
(Eng)
|
| Vol 13, No 4 (2013) |
Oncology |
FAK and HAS Inhibition Synergistically Decrease Colon Cancer Cell Viability and Affect Expression of Critical Genes |
(Eng)
|
